Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users

NCT00828659 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2019-09-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the abuse potential of lorcaserin in healthy recreational polydrug users.

Conditions

  • Drug Abuse
  • Healthy

Interventions

DRUG

Placebo

DRUG

Active Comparator #1

DRUG

Active Comparator #2

DRUG

Active Comparator #3

DRUG

Lorcaserin Dose #1

DRUG

Lorcaserin Dose #2

DRUG

Lorcaserin Dose #3

Sponsors & Collaborators

  • Eisai Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828659 on ClinicalTrials.gov